Realize the Full Benefit of EMEND
3 days of dosing are required
- For patients at risk of CINV due to HEC or MEC, EMEND always should be taken on Days 1, 2, and 3 of each cycle, in combination with a 5-HT3 receptor antagonist and a corticosteroid, even if patients do not experience nausea and vomiting on Day 1.
- All 3 doses of EMEND are required for the full 5 days of CINV protection.
Realize the full benefit
Talk with your patients
- Explain the importance of taking EMEND on Days 2 and 3 of every cycle, even if patients do not experience nausea and vomiting on Day 1.
- Remember that the ACT Program is available to provide assistance to qualified patients.
-
Ensure that managed care and Medicare patients know that EMEND usually is covered:
EMEND has favorable formulary status
- 96% of patients with managed care plans have EMEND on Tier 2 or Tier 3.
- 100% of patients with Medicare Part D plans have EMEND on Tier 2 or Tier 3.
| Common Copayments for EMEND | ||
| Plan Coverage for EMEND | National Copayment | |
|---|---|---|
| Managed care plans | Tier 2 status for 73% of covered lives | $241 |
| Tier 3 status for 23% of covered lives | $451 | |
| Medicare Part D plans | Tier 2 status for 75% of covered lives | $301,a |
| Tier 3 status for 25% of covered lives | $601,a | |
aThe table shows the most common copayment amount as the mode, not the average, for Medicare products.
To view PDF documents, you will need the free Adobe Acrobat Reader program.
Download Adobe Acrobat ReaderFor information about Merck products or services, please call 866-448-7590. The Merck National Service Center will be pleased to assist you Monday through Friday from 8 AM to 7 PM ET.
PRIVACY POLICY